Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC).
BMC Cancer. 2020 Dec 3;20(1):1185. doi: 10.1186/s12885-020-07690-8.
BMC Cancer. 2020.
PMID:33272262
Free PMC article.
Review.